Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 13776 | 27.34 |
09:34 ET | 1220 | 27.26 |
09:36 ET | 1300 | 27.15 |
09:38 ET | 2798 | 27.23 |
09:39 ET | 2969 | 27.18 |
09:41 ET | 9364 | 27.225 |
09:43 ET | 7267 | 27.16 |
09:45 ET | 6140 | 27.23 |
09:48 ET | 6256 | 27.185 |
09:50 ET | 3300 | 27.175 |
09:52 ET | 3000 | 27.195 |
09:54 ET | 1800 | 27.25 |
09:56 ET | 2384 | 27.245 |
09:57 ET | 21829 | 27.17 |
09:59 ET | 4290 | 27.17 |
10:01 ET | 3284 | 27.19 |
10:03 ET | 2900 | 27.17 |
10:06 ET | 4459 | 27.24 |
10:08 ET | 8565 | 27.235 |
10:10 ET | 4998 | 27.25 |
10:12 ET | 5643 | 27.255 |
10:14 ET | 5889 | 27.28 |
10:15 ET | 8503 | 27.23 |
10:17 ET | 1235 | 27.275 |
10:19 ET | 5811 | 27.235 |
10:21 ET | 2717 | 27.2 |
10:24 ET | 2600 | 27.2 |
10:26 ET | 55720 | 27.16 |
10:28 ET | 3390 | 27.16 |
10:30 ET | 2327 | 27.135 |
10:32 ET | 77936 | 27.14 |
10:33 ET | 3238 | 27.195 |
10:35 ET | 4218 | 27.19 |
10:37 ET | 1600 | 27.175 |
10:39 ET | 13533 | 27.175 |
10:42 ET | 67400 | 27.16 |
10:44 ET | 6201 | 27.13 |
10:46 ET | 2500 | 27.14 |
10:48 ET | 1555 | 27.12 |
10:50 ET | 6233 | 27.11 |
10:51 ET | 6124 | 27.1399 |
10:53 ET | 1674 | 27.1497 |
10:55 ET | 3605 | 27.125 |
10:57 ET | 1894 | 27.115 |
11:00 ET | 3200 | 27.13 |
11:02 ET | 4972 | 27.13 |
11:04 ET | 3797 | 27.14 |
11:06 ET | 2750 | 27.155 |
11:08 ET | 4602 | 27.13 |
11:09 ET | 1200 | 27.13 |
11:11 ET | 2170 | 27.1394 |
11:13 ET | 100 | 27.135 |
11:15 ET | 7817 | 27.21 |
11:18 ET | 4829 | 27.195 |
11:20 ET | 3550 | 27.205 |
11:22 ET | 600 | 27.21 |
11:24 ET | 1400 | 27.23 |
11:26 ET | 3846 | 27.225 |
11:27 ET | 1609 | 27.23 |
11:29 ET | 1300 | 27.205 |
11:31 ET | 2818 | 27.21 |
11:33 ET | 2800 | 27.195 |
11:36 ET | 839 | 27.2 |
11:38 ET | 1000 | 27.2 |
11:40 ET | 1800 | 27.22 |
11:42 ET | 1725 | 27.2466 |
11:44 ET | 3800 | 27.25 |
11:45 ET | 1600 | 27.255 |
11:47 ET | 400 | 27.245 |
11:49 ET | 1000 | 27.245 |
11:51 ET | 1522 | 27.25 |
11:54 ET | 239 | 27.25 |
11:56 ET | 1200 | 27.25 |
11:58 ET | 8561 | 27.23 |
12:00 ET | 1870 | 27.212 |
12:02 ET | 1700 | 27.205 |
12:03 ET | 2300 | 27.205 |
12:05 ET | 17213 | 27.215 |
12:07 ET | 1058 | 27.21 |
12:09 ET | 900 | 27.195 |
12:12 ET | 4308 | 27.245 |
12:14 ET | 1355 | 27.25 |
12:16 ET | 3703 | 27.26 |
12:18 ET | 2380 | 27.24 |
12:20 ET | 2061 | 27.235 |
12:21 ET | 5028 | 27.21 |
12:23 ET | 3285 | 27.195 |
12:25 ET | 4968 | 27.215 |
12:27 ET | 4735 | 27.245 |
12:30 ET | 2400 | 27.255 |
12:32 ET | 200 | 27.255 |
12:34 ET | 1085 | 27.255 |
12:36 ET | 7024 | 27.265 |
12:38 ET | 9124 | 27.295 |
12:39 ET | 7417 | 27.33 |
12:41 ET | 13845 | 27.35 |
12:43 ET | 11092 | 27.375 |
12:45 ET | 3186 | 27.375 |
12:48 ET | 5900 | 27.405 |
12:50 ET | 8384 | 27.415 |
12:52 ET | 25442 | 27.44 |
12:54 ET | 9334 | 27.47 |
12:56 ET | 6097 | 27.48 |
12:57 ET | 14819 | 27.395 |
12:59 ET | 2441 | 27.405 |
01:01 ET | 1746 | 27.405 |
01:03 ET | 1500 | 27.435 |
01:06 ET | 3349 | 27.47 |
01:08 ET | 3988 | 27.42 |
01:10 ET | 1800 | 27.42 |
01:12 ET | 3492 | 27.4074 |
01:14 ET | 3041 | 27.36 |
01:15 ET | 1949 | 27.38 |
01:17 ET | 600 | 27.37 |
01:19 ET | 2441 | 27.39 |
01:21 ET | 3324 | 27.39 |
01:24 ET | 2429 | 27.375 |
01:26 ET | 841 | 27.361 |
01:28 ET | 5705 | 27.37 |
01:30 ET | 6648 | 27.35 |
01:32 ET | 2058 | 27.3603 |
01:33 ET | 1400 | 27.345 |
01:35 ET | 7905 | 27.315 |
01:37 ET | 6158 | 27.32 |
01:39 ET | 1894 | 27.335 |
01:42 ET | 1400 | 27.335 |
01:44 ET | 300 | 27.335 |
01:46 ET | 6601 | 27.385 |
01:48 ET | 3589 | 27.37 |
01:50 ET | 3367 | 27.4 |
01:51 ET | 2300 | 27.38 |
01:53 ET | 2558 | 27.385 |
01:55 ET | 2983 | 27.385 |
01:57 ET | 600 | 27.38 |
02:00 ET | 2337 | 27.385 |
02:02 ET | 5985 | 27.39 |
02:04 ET | 1100 | 27.385 |
02:06 ET | 1700 | 27.395 |
02:08 ET | 5790 | 27.405 |
02:09 ET | 5626 | 27.385 |
02:11 ET | 3392 | 27.405 |
02:13 ET | 3300 | 27.44 |
02:15 ET | 2200 | 27.43 |
02:18 ET | 2501 | 27.435 |
02:20 ET | 2279 | 27.435 |
02:22 ET | 2235 | 27.45 |
02:24 ET | 4867 | 27.455 |
02:26 ET | 1200 | 27.455 |
02:27 ET | 1000 | 27.45 |
02:29 ET | 10541 | 27.455 |
02:31 ET | 1000 | 27.465 |
02:33 ET | 4632 | 27.49 |
02:36 ET | 3611 | 27.5 |
02:38 ET | 1139 | 27.495 |
02:40 ET | 3893 | 27.505 |
02:42 ET | 5628 | 27.52 |
02:44 ET | 1700 | 27.52 |
02:45 ET | 149683 | 27.52 |
02:47 ET | 2736 | 27.535 |
02:49 ET | 2800 | 27.55 |
02:51 ET | 68216 | 27.5 |
02:54 ET | 2943 | 27.52 |
02:56 ET | 4465 | 27.53 |
02:58 ET | 4140 | 27.5 |
03:00 ET | 3100 | 27.5 |
03:02 ET | 9314 | 27.475 |
03:03 ET | 5162 | 27.505 |
03:05 ET | 2500 | 27.525 |
03:07 ET | 6016 | 27.52 |
03:09 ET | 3643 | 27.53 |
03:12 ET | 3861 | 27.535 |
03:14 ET | 5130 | 27.545 |
03:16 ET | 4852 | 27.5 |
03:18 ET | 2890 | 27.491 |
03:20 ET | 2671 | 27.475 |
03:21 ET | 5712 | 27.425 |
03:23 ET | 2700 | 27.415 |
03:25 ET | 5800 | 27.41 |
03:27 ET | 7170 | 27.425 |
03:30 ET | 7195 | 27.38 |
03:32 ET | 2911 | 27.375 |
03:34 ET | 4788 | 27.385 |
03:36 ET | 3791 | 27.37 |
03:38 ET | 4824 | 27.395 |
03:39 ET | 6355 | 27.365 |
03:41 ET | 3511 | 27.36 |
03:43 ET | 15735 | 27.355 |
03:45 ET | 8125 | 27.365 |
03:48 ET | 8396 | 27.35 |
03:50 ET | 8040 | 27.345 |
03:52 ET | 12384 | 27.395 |
03:54 ET | 30514 | 27.375 |
03:56 ET | 41513 | 27.42 |
03:57 ET | 46458 | 27.4 |
03:59 ET | 105905 | 27.42 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.4B | 15.4x | +1.83% |
Amneal Pharmaceuticals Inc | 2.1B | -12.5x | --- |
Catalent Inc | 10.2B | -8.6x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.8x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.3B | 16.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.4B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.06% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.4x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | 13.7x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.